Benefit of weight based dosages of Ribavirin (RBV) in combination with PegInterferon (PegIFN) alpha 2a in naive patients with HCV2 and HCV3: results of an Italian Randomized Controlled Trial, the WRITE study
HEPATOLOGY(2012)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined